{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Atopic dermatitis", "liposomes", "medicinal plants", "nanomedicine", "nanoparticles.", "phytoconstituents"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37888809", "DateCompleted": {"Year": "2024", "Month": "06", "Day": "06"}, "DateRevised": {"Year": "2024", "Month": "06", "Day": "06"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/0113892010245092230922180341"], "Journal": {"ISSN": "1873-4316", "JournalIssue": {"Volume": "25", "Issue": "6", "PubDate": {"Year": "2024"}}, "Title": "Current pharmaceutical biotechnology", "ISOAbbreviation": "Curr Pharm Biotechnol"}, "ArticleTitle": "Comprehensive Review on Phytoconstituents-based Nanomedicine for the Treatment of Atopic Dermatitis.", "Pagination": {"StartPage": "737", "EndPage": "756", "MedlinePgn": "737-756"}, "Abstract": {"AbstractText": ["Atopic dermatitis (AD) is known as a chronic disease characterized by eczematous and pruritus skin lesions. The pathology behind atopic dermatitis etiology is loss of epidermal barrier, which prevents the production of protein filaggrin that can induce T-cell infiltration and inflammation. Treatment of AD is majorly based on limiting skin repair as well as reducing inflammation and itching. There are several remedies available for the treatment of AD, such as Janus kinase and calcineurin inhibitors, topical corticosteroids, and phosphodiesterase-4 inhibitors. The conventional formulations in the market have limited safety and efficacy. Hence, effective treatment of atopic dermatitis requires the development of novel, efficacious, reliable, and specific therapies. Recent research data have revealed that some naturally occurring medicinal plants have potential applications in the management of AD through different mechanisms. The nanotechnology-based therapeutics have gained a lot of attention in the last decade for the improvement in the activity of drugs having low absorption due to poor solubility, thus leading to lesser bioavailability. Therapies based on nanotechnology can be an effective way to overcome these obstacles. Due to their effective propensity to provide better drug diffusion and bioavailability as well as drug targeting potential at the desired site of action, these approaches may have decreased adverse drug effects, better penetration, and enhanced therapeutic efficacy. Hence, this review highlights the potential of phytoconstituents-based novel formulations for the treatment of atopic dermatitis. Furthermore, recent patents on therapeutic approaches to atopic dermatitis have also been briefly described."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmaceutical Research, GLA University, Mathura, 281406, U.P. India."}], "LastName": "Varshney", "ForeName": "Mayuri", "Initials": "M"}, {"Identifier": ["0000-0001-9429-2857"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmaceutical Research, GLA University, Mathura, 281406, U.P. India."}], "LastName": "Bahadur", "ForeName": "Shiv", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Curr Pharm Biotechnol", "NlmUniqueID": "100960530", "ISSNLinking": "1389-2010"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Filaggrin Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "FLG protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Dermatitis, Atopic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["methods"], "DescriptorName": "Nanomedicine"}, {"QualifierName": [], "DescriptorName": "Filaggrin Proteins"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["therapeutic use", "chemistry", "pharmacology", "administration & dosage"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Mandlik D.S.; Mandlik S.K.; Atopic dermatitis: New insight into the etiology, pathogenesis, diagnosis and novel treatment strategies. Immunopharmacol Immunotoxicol 2021,43(2),105-125", "ArticleIdList": ["10.1080/08923973.2021.1889583", "33645388"]}, {"Citation": "Ahmed A.; Solman L.; Williams H.C.; Magnitude of benefit for topical crisaborole in the treatment of atopic dermatitis in children and adults does not look promising: A critical appraisal. Br J Dermatol 2018,178(3),659-662", "ArticleIdList": ["10.1111/bjd.16046", "29205284"]}, {"Citation": "Holm J.G.; Thomsen S.F.; Omalizumab for atopic dermatitis: Evidence for and against its use. G Ital Dermatol Venereol 2019,154(4),480-487", "ArticleIdList": ["10.23736/S0392-0488.19.06302-8", "30717578"]}, {"Citation": "Yan F.; Li F.; Liu J.; Ye S.; Zhang Y.; Jia J.; Li H.; Chen D.; Mo X.; The formulae and biologically active ingredients of Chinese herbal medicines for the treatment of atopic dermatitis. Biomed Pharmacother 2020,127,110142", "ArticleIdList": ["10.1016/j.biopha.2020.110142", "32330795"]}, {"Citation": "M\u00f6bus L.; Rodriguez E.; Harder I.; Schwarz A.; Wehkamp U.; St\u00f6lzl D.; Boraczynski N.; Gerdes S.; Litman T.; Kleinheinz A.; Abraham S.; Heratizadeh A.; Handrick C.; Haufe E.; Schmitt J.; Werfel T.; Weidinger S.; Elevated NK-cell transcriptional signature and dysbalance of resting and activated NK cells in atopic dermatitis. J Allergy Clin Immunol 2021,147(5),1959-1965.e2", "ArticleIdList": ["10.1016/j.jaci.2020.11.022", "33390269"]}, {"Citation": "Palmer C.N.A.; Irvine A.D.; Terron-Kwiatkowski A.; Zhao Y.; Liao H.; Lee S.P.; Goudie D.R.; Sandilands A.; Campbell L.E.; Smith F.J.D.; O\u2019Regan G.M.; Watson R.M.; Cecil J.E.; Bale S.J.; Compton J.G.; DiGiovanna J.J.; Fleckman P.; Lewis-Jones S.; Arseculeratne G.; Sergeant A.; Munro C.S.; El Houate B.; McElreavey K.; Halkjaer L.B.; Bisgaard H.; Mukhopadhyay S.; McLean W.H.I.; Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006,38(4),441-446", "ArticleIdList": ["10.1038/ng1767", "16550169"]}, {"Citation": "Li H.; Zhang Z.; Zhang H.; Guo Y.; Yao Z.; Update on the pathogenesis and therapy of Atopic Dermatitis. Clin Rev Allergy Immunol 2021,61(3),324-338", "ArticleIdList": ["10.1007/s12016-021-08880-3", "34338977"]}, {"Citation": "Sung Y.Y.; Kim H.; Crocin ameliorates Atopic Dermatitis symptoms by down regulation of Th2 response via blocking of NF-\u03baB/STAT6 signaling pathways in mice. Nutrients 2018,10(11),1625", "ArticleIdList": ["10.3390/nu10111625", "30400140"]}, {"Citation": "Pribowo A.; Girish J.; Gustiananda M.; Nandhira R.G.; Hartrianti P.; Potential of Tamanu (Calophyllum inophyllum) Oil for Atopic Dermatitis Treatment. Evid Based Complement Alternat Med 2021,2021,1-9", "ArticleIdList": ["10.1155/2021/6332867", "35069754"]}, {"Citation": "Luger T.; Amagai M.; Dreno B.; Dagnelie M.A.; Liao W.; Kabashima K.; Schikowski T.; Proksch E.; Elias P.M.; Simon M.; Simpson E.; Grinich E.; Schmuth M.; Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents. J Dermatol Sci 2021,102(3),142-157", "ArticleIdList": ["10.1016/j.jdermsci.2021.04.007", "34116898"]}, {"Citation": "Akan A.; Dibek-M\u0131s\u0131rl\u0131o\u011flu E.; Civelek E.; Vezir E.; Kocaba\u015f C.N.; Diagnosis of atopic dermatitis in children: Comparison of the Hanifin-Rajka and the United Kingdom Working Party criteria. Allergol Immunopathol (Madr) 2020,48(2),175-181", "ArticleIdList": ["10.1016/j.aller.2019.07.008", "31611041"]}, {"Citation": "Cheng R.; Zhang H.; Zong W.; Tang J.; Han X.; Zhang L.; Zhang X.; Gu H.; Shu Y.; Peng G.; Huang L.; Liu Q.; Gao X.; Guo Y.; Yao Z.; Development and validation of new diagnostic criteria for atopic dermatitis in children of China. J Eur Acad Dermatol Venereol 2020,34(3),542-548", "ArticleIdList": ["10.1111/jdv.15979", "31568595"]}, {"Citation": "Manz J.; Rodr\u00edguez E.; ElSharawy A.; Oesau E.M.; Petersen B.S.; Baurecht H.; Mayr G.; Weber S.; Harder J.; Reischl E.; Schwarz A.; Novak N.; Franke A.; Weidinger S.; Targeted resequencing and functional testing identifies low-frequency missense variants in the gene encoding GARP as significant contributors to Atopic Dermatitis risk. J Invest Dermatol 2016,136(12),2380-2386", "ArticleIdList": ["10.1016/j.jid.2016.07.009", "27448748"]}, {"Citation": "Wu S.; Pang Y.; He Y.; Zhang X.; Peng L.; Guo J.; Zeng J.; A comprehensive review of natural products against atopic dermatitis: Flavonoids, alkaloids, terpenes, glycosides and other compounds. Biomed Pharmacother 2021,140,111741", "ArticleIdList": ["10.1016/j.biopha.2021.111741", "34087696"]}, {"Citation": "Kumar S.; Pandey A.K.; Chemistry and biological activities of flavonoids: An overview. ScientificWorldJournal 2013,2013,1-16", "ArticleIdList": ["10.1155/2013/162750", "24470791"]}, {"Citation": "Panche A.N.; Diwan A.D.; Chandra S.R.; Flavonoids: An overview. J Nutr Sci 2016,5,e47", "ArticleIdList": ["10.1017/jns.2016.41", "28620474"]}, {"Citation": "Lee H.S.; Kim E.N.; Jeong G.S.; Oral administration of Liquiritigenin confers protection from Atopic Dermatitis through the inhibition of T cell activation. Biomolecules 2020,10(5),786", "ArticleIdList": ["10.3390/biom10050786", "32438694"]}, {"Citation": "Lee D.; Park J.; Choi J.; Jang H.; Seol J.; Anti-inflammatory effects of natural flavonoid diosmetin in IL-4 and LPS-induced macrophage activation and atopic dermatitis model. Int Immunopharmacol 2020,89(Pt A),107046", "ArticleIdList": ["10.1016/j.intimp.2020.107046", "33045572"]}, {"Citation": "Orita K.; Hiramoto K.; Kobayashi H.; Ishii M.; Sekiyama A.; Inoue M.; Inducible nitric oxide synthase (iNOS) and \u03b1-melanocyte-stimulating hormones of iNOS origin play important roles in the allergic reactions of atopic dermatitis in mice. Exp Dermatol 2011,20(11),911-914", "ArticleIdList": ["10.1111/j.1600-0625.2011.01360.x", "21895774"]}, {"Citation": "Park S.; Bong S.K.; Lee J.W.; Park N.J.; Choi Y.; Kim S.M.; Yang M.H.; Kim Y.K.; Kim S.N.; Diosmetin and its glycoside, diosmin, improve Atopic Dermatitis-like lesions in 2, 4-dinitrochlorobenzene-induced murine models. Biomol Ther (Seoul) 2020,28(6),542-548", "ArticleIdList": ["10.4062/biomolther.2020.135", "32938818"]}, {"Citation": "Hou D.D.; Zhang W.; Gao Y.L.; Sun Y.; Wang H.X.; Qi R.Q.; Chen H.D.; Gao X.H.; Anti-inflammatory effects of quercetin in a mouse model of MC903-induced atopic dermatitis. Int Immunopharmacol 2019,74,105676", "ArticleIdList": ["10.1016/j.intimp.2019.105676", "31181406"]}, {"Citation": "Kim T.H.; Kim G.D.; Ahn H.J.; Cho J.J.; Park Y.S.; Park C.S.; The inhibitory effect of naringenin on atopic dermatitis induced by DNFB in NC/Nga mice. Life Sci 2013,93(15),516-524", "ArticleIdList": ["10.1016/j.lfs.2013.07.027", "23933131"]}, {"Citation": "Karuppagounder V.; Arumugam S.; Thandavarayan R.A.; Sreedhar R.; Giridharan V.V.; Pitchaimani V.; Afrin R.; Harima M.; Krishnamurthy P.; Suzuki K.; Nakamura M.; Ueno K.; Watanabe K.; Naringenin ameliorates skin inflammation and accelerates phenotypic reprogramming from M1 to M2 macrophage polarization in atopic dermatitis NC/Nga mouse model. Exp Dermatol 2016,25(5),404-407", "ArticleIdList": ["10.1111/exd.12962", "26836240"]}, {"Citation": "Moon P.D.; Choi I.H.; Kim H.M.; Naringenin suppresses the production of thymic stromal lymphopoietin through the blockade of RIP2 and caspase-1 signal cascade in mast cells. Eur J Pharmacol 2011,671(1-3),128-132", "ArticleIdList": ["10.1016/j.ejphar.2011.09.163", "21963452"]}, {"Citation": "Nagula R.L.; Wairkar S.; Cellulose microsponges based gel of naringenin for atopic dermatitis: Design, optimization, in vitro and in vivo investigation. Int J Biol Macromol 2020,164,717-725", "ArticleIdList": ["10.1016/j.ijbiomac.2020.07.168", "32698069"]}, {"Citation": "Yun M.Y.; Yang J.H.; Kim D.K.; Cheong K.J.; Song H.H.; Kim D.H.; Cheong K.J.; Kim Y.I.; Shin S.C.; Therapeutic effects of Baicalein on atopic dermatitis-like skin lesions of NC/Nga mice induced by dermatophagoides pteronyssinus. Int Immunopharmacol 2010,10(9),1142-1148", "ArticleIdList": ["10.1016/j.intimp.2010.06.020", "20621172"]}, {"Citation": "Huang K.F.; Ma K.H.; Liu P.S.; Chen B.W.; Chueh S.H.; Baicalein increases keratin 1 and 10 expression in HaCaT keratinocytes via TRPV4 receptor activation. Exp Dermatol 2016,25(8),623-629", "ArticleIdList": ["10.1111/exd.13024", "27060689"]}, {"Citation": "Nguyen L.T.H.; Oh T.W.; Nguyen U.T.; Choi M.J.; Yang I.J.; Shin H.M.; A natural compound mixture containing Arctigenin, Hederagenin, and Baicalein alleviates Atopic Dermatitis in mice by regulating HPA Axis and immune activity. Evid Based Complement Alternat Med 2020,2020,1-13", "ArticleIdList": ["10.1155/2020/1970349", "32714398"]}, {"Citation": "Yang L.; St\u00f6ckigt J.; Trends for diverse production strategies of plant medicinal alkaloids. Nat Prod Rep 2010,27(10),1469-1479", "ArticleIdList": ["10.1039/c005378c", "20730220"]}, {"Citation": "Aiello A.; Fattorusso E.; Imperatore C.; Irace C.; Luciano P.; Menna M.; Santamaria R.; Vitalone R.; Zorrimidazolone, a bioactive alkaloid from the non-indigenous mediterranean stolidobranch Polyandrocarpa zorritensis. Mar Drugs 2011,9(6),1157-1165", "ArticleIdList": ["10.3390/md9061157", "21747753"]}, {"Citation": "Choi D.W.; Jung S.Y.; Shon D.H.; Shin H.S.; Piperine Ameliorates Trimellitic anhydride-induced Atopic Dermatitis-like symptoms by suppressing Th2-mediated immune responses via inhibition of STAT6 phosphorylation. Molecules 2020,25(9),2186", "ArticleIdList": ["10.3390/molecules25092186", "32392825"]}, {"Citation": "Chen X.; Lin J.; Liang Q.; Chen X.; Wu Z.; Pseudoephedrine alleviates atopic dermatitis-like inflammatory responses in vivo and in vitro. Life Sci 2020,258,118139", "ArticleIdList": ["10.1016/j.lfs.2020.118139", "32721463"]}, {"Citation": "Wu S.; Yu D.; Liu W.; Zhang J.; Liu X.; Wang J.; Yu M.; Li Z.; Chen Q.; Li X.; Ye X.; Magnoflorine from Coptis chinese has the potential to treat DNCB-induced Atopic dermatits by inhibiting apoptosis of keratinocyte. Bioorg Med Chem 2020,28(2),115093", "ArticleIdList": ["10.1016/j.bmc.2019.115093", "31859028"]}, {"Citation": "Lai J.; Liu Y.; Liu C.; Qi M.; Liu R.; Zhu X.; Zhou Q.; Chen Y.; Guo A.; Hu C.; Indirubin inhibits LPS-induced inflammation via TLR4 abrogation mediated by the NF-kB and MAPK signaling pathways. Inflammation 2017,40(1),1-12", "ArticleIdList": ["10.1007/s10753-016-0447-7", "27718095"]}, {"Citation": "Kim M.H.; Choi Y.Y.; Yang G.; Cho I.H.; Nam D.; Yang W.M.; Indirubin, a purple 3,2- bisindole, inhibited allergic contact dermatitis via regulating T helper (Th)-mediated immune system in DNCB-induced model. J Ethnopharmacol 2013,145(1),214-219", "ArticleIdList": ["10.1016/j.jep.2012.10.055", "23149289"]}, {"Citation": "Han N.R.; Moon P.D.; Kim H.M.; Jeong H.J.; Tryptanthrin ameliorates atopic dermatitis through down-regulation of TSLP. Arch Biochem Biophys 2014,542,14-20", "ArticleIdList": ["10.1016/j.abb.2013.11.010", "24295961"]}, {"Citation": "Hortelano S.; Gonz\u00e1lez-Cofrade L.; Cuadrado I.; de las Heras B.; Current status of terpenoids as inflammasome inhibitors. Biochem Pharmacol 2020,172,113739", "ArticleIdList": ["10.1016/j.bcp.2019.113739", "31786260"]}, {"Citation": "Park J.H.; Yeo I.J.; Han J.H.; Suh J.W.; Lee H.P.; Hong J.T.; Anti-inflammatory effect of astaxanthin in phthalic anhydride-induced atopic dermatitis animal model. Exp Dermatol 2018,27(4),378-385", "ArticleIdList": ["10.1111/exd.13437", "28887839"]}, {"Citation": "Park J.H.; Yeo I.J.; Jang J.S.; Kim K.C.; Park M.H.; Lee H.P.; Han S.B.; Hong J.T.; Combination effect of titrated extract of Centella asiatica and astaxanthin in a mouse model of phthalic anhydride-induced Atopic Dermatitis. Allergy Asthma Immunol Res 2019,11(4),548-559", "ArticleIdList": ["10.4168/aair.2019.11.4.548", "31172723"]}, {"Citation": "Yoshihisa Y.; Andoh T.; Matsunaga K.; Rehman M.U.; Maoka T.; Shimizu T.; Efficacy of astaxanthin for the treatment of Atopic Dermatitis in a murine model. PLoS One 2016,11(3),e0152288", "ArticleIdList": ["10.1371/journal.pone.0152288", "27023003"]}, {"Citation": "Natsume C.; Aoki N.; Aoyama T.; Senda K.; Matsui M.; Ikegami A.; Tanaka K.; Azuma Y.T.; Fujita T.; Fucoxanthin ameliorates Atopic Dermatitis symptoms by regulating keratinocytes and regulatory innate lymphoid cells. Int J Mol Sci 2020,21(6),2180", "ArticleIdList": ["10.3390/ijms21062180", "32235696"]}, {"Citation": "Yang H.; Jung E.M.; Ahn C.; Lee G.S.; Lee S.Y.; Kim S.H.; Choi I.G.; Park M.J.; Lee S.S.; Choi D.H.; Jeung E.B.; Elemol from Chamaecyparis obtusa ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis. Int J Mol Med 2015,36(2),463-472", "ArticleIdList": ["10.3892/ijmm.2015.2228", "26035417"]}, {"Citation": "Lin G.; Gao S.; Cheng J.; Li Y.; Shan L.; Hu Z.; 1 \u03b2 -Hydroxyalantolactone, a sesquiterpene lactone from Inula japonica, attenuates atopic dermatitis-like skin lesions induced by 2,4-dinitrochlorobenzene in the mouse. Pharm Biol 2016,54(3),516-522", "ArticleIdList": ["10.3109/13880209.2015.1050745", "26017682"]}, {"Citation": "Choi J.H.; Jin S.W.; Han E.H.; Park B.H.; Kim H.G.; Khanal T.; Hwang Y.P.; Do M.T.; Lee H.S.; Chung Y.C.; Kim H.S.; Jeong T.C.; Jeong H.G.; Platycodon grandiflorum root-derived saponins attenuate atopic dermatitis-like skin lesions via suppression of NF-\u03baB and STAT1 and activation of Nrf2/ARE-mediated heme oxygenase-1. Phytomedicine 2014,21(8-9),1053-1061", "ArticleIdList": ["10.1016/j.phymed.2014.04.011", "24854572"]}, {"Citation": "Bartnik M.; Facey P.C.; GlycosidesPharmacognosy 2017,101-161", "ArticleIdList": ["10.1016/B978-0-12-802104-0.00008-1"]}, {"Citation": "Ahn J.Y.; Choi S.E.; Jeong M.S.; Park K.H.; Moon N.J.; Joo S.S.; Lee C.S.; Choi Y.W.; Li K.; Lee M.K.; Lee M.W.; Seo S.J.; Effect of taxifolin glycoside on atopic dermatitis-like skin lesions in NC/Nga mice. Phytother Res 2010,24(7),1071-1077", "ArticleIdList": ["10.1002/ptr.3084", "20041431"]}, {"Citation": "Kim J.Y.; Lee O.S.; Ha S.; Kim J.H.; Park G.; Kim J.K.; Oh C.H.; In vivo assessment of the effect of taxifolin glycoside on atopic dermatitis-like skin lesions using biomedical tools in NC/Nga mice. Clin Exp Dermatol 2015,40(5),547-555", "ArticleIdList": ["10.1111/ced.12522", "25475067"]}, {"Citation": "Kang M.J.; Eum J.Y.; Park S.H.; Kang M.H.; Park K.H.; Choi S.E.; Lee M.W.; Kang K.H.; Oh C.H.; Choi Y.W.; Pep-1 peptide-conjugated elastic liposomal formulation of taxifolin glycoside for the treatment of atopic dermatitis in NC/Nga mice. Int J Pharm 2010,402(1-2),198-204", "ArticleIdList": ["10.1016/j.ijpharm.2010.09.030", "20888893"]}, {"Citation": "Jegal J.; Park N.J.; Jo B.G.; Bong S.K.; Jegal H.; Yang M.; Kim S.N.; Anti-Atopic properties of gracillin isolated from Dioscorea quinqueloba on 2, 4-dinitrochlorobenzene-induced skin lesions in mice. Nutrients 2018,10(9),1205", "ArticleIdList": ["10.3390/nu10091205", "30200442"]}, {"Citation": "Ingawale D.K.; Mandlik S.K.; Patel S.S.; Anti-inflammatory potential of hecogenin on atopic dermatitis and airway hyper-responsiveness by regulation of pro-inflammatory cytokines. Immunopharmacol Immunotoxicol 2019,41(2),327-336", "ArticleIdList": ["10.1080/08923973.2019.1608445", "31039648"]}, {"Citation": "Georgiev M.; Pastore S.; Lulli D.; Alipieva K.; Kostyuk V.; Potapovich A.; Panetta M.; Korkina L.; Verbascum xanthophoeniceum-derived phenylethanoid glycosides are potent inhibitors of inflammatory chemokines in dormant and interferon-gamma-stimulated human keratinocytes. J Ethnopharmacol 2012,144(3),754-760", "ArticleIdList": ["10.1016/j.jep.2012.10.035", "23117092"]}, {"Citation": "Li Y.; Yu H.; Jin Y.; Li M.; Qu C.; Verbascoside alleviates Atopic Dermatitis-like symptoms in mice via its potent anti-inflammatory effect. Int Arch Allergy Immunol 2018,175(4),220-230", "ArticleIdList": ["10.1159/000486958", "29587260"]}, {"Citation": "Karuppagounder V.; Arumugam S.; Thandavarayan R.A.; Pitchaimani V.; Sreedhar R.; Afrin R.; Harima M.; Suzuki H.; Nomoto M.; Miyashita S.; Suzuki K.; Nakamura M.; Ueno K.; Watanabe K.; Tannic acid modulates NF\u03baB signaling pathway and skin inflammation in NC/Nga mice through PPAR\u03b3 expression. Cytokine 2015,76(2),206-213", "ArticleIdList": ["10.1016/j.cyto.2015.05.016", "26049169"]}, {"Citation": "Noh S.U.; Cho E.A.; Kim H.O.; Park Y.M.; Epigallocatechin-3-gallate improves Dermatophagoides pteronissinus extract-induced atopic dermatitis-like skin lesions in NC/Nga mice by suppressing macrophage migration inhibitory factor. Int Immunopharmacol 2008,8(9),1172-1182", "ArticleIdList": ["10.1016/j.intimp.2008.04.002", "18602062"]}, {"Citation": "Shimizu T.; Abe R.; Ohkawara A.; Mizue Y.; Nishihira J.; Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis. Biochem Biophys Res Commun 1997,240(1),173-178", "ArticleIdList": ["10.1006/bbrc.1997.7633", "9367905"]}, {"Citation": "An E.J.; Kim Y.; Lee S.H.; Choi S.H.; Chung W.S.; Jang H.J.; Ophiopogonin D ameliorates DNCB-induced atopic dermatitis-like lesions in BALB/c mice and TNF-\u03b1- inflamed HaCaT cell. Biochem Biophys Res Commun 2020,522(1),40-46", "ArticleIdList": ["10.1016/j.bbrc.2019.10.190", "31735336"]}, {"Citation": "Shenefelt PD; Herbal Medicine: Biomolecular and Clinical Aspects 2011", "ArticleIdList": ["10.1201/b10787-19"]}, {"Citation": "Hoffmann J.; Gendrisch F.; Schempp C.M.; W\u00f6lfle U.; New herbal biomedicines for the topical treatment of dermatological disorders. Biomedicines 2020,8(2),27", "ArticleIdList": ["10.3390/biomedicines8020027", "32046246"]}, {"Citation": "Bae M.J.; Lim S.; Lee D.S.; Ko K.R.; Lee W.; Kim S.; Water soluble extracts from Actinidia arguta, PG102, attenuates house dust mite-induced murine atopic dermatitis by inhibiting the mTOR pathway with Treg generation. J Ethnopharmacol 2016,193,96-106", "ArticleIdList": ["10.1016/j.jep.2016.08.004", "27496579"]}, {"Citation": "Han H.M.; Kim S.J.; Kim J.S.; Kim B.H.; Lee H.W.; Lee Y.T.; Kang K.H.; Ameliorative effects of Artemisia argyi Folium extract on 2,4-dinitrochlorobenzene-induced atopic dermatitis-like lesions in BALB/c mice. Mol Med Rep 2016,14(4),3206-3214", "ArticleIdList": ["10.3892/mmr.2016.5657", "27571702"]}, {"Citation": "Ryu K.J.; Yoou M.S.; Seo Y.; Yoon K.W.; Kim H.M.; Jeong H.J.; Therapeutic effects of Artemisia scoparia Waldst. et Kitaib in a murine model of atopic dermatitis. Clin Exp Dermatol 2018,43(7),798-805", "ArticleIdList": ["10.1111/ced.13565", "29740850"]}, {"Citation": "Ku J.M.; Hong S.H.; Kim H.I.; Seo H.S.; Shin Y.C.; Ko S.G.; Effects of Angelicae dahuricae Radix on 2, 4-dinitrochlorobenzene-induced Atopic Dermatitis-like skin lesions in mice model. BMC Complement Altern Med 2017,17(1),98", "ArticleIdList": ["10.1186/s12906-017-1584-8", "28173791"]}, {"Citation": "Qi X.F.; Kim D.H.; Yoon Y.S.; Li J.H.; Jin D.; Deung Y.K.; Lee K.J.; Effects of Bambusae caulis in Liquamen on the development of atopic dermatitis-like skin lesions in hairless mice. J Ethnopharmacol 2009,123(2),195-200", "ArticleIdList": ["10.1016/j.jep.2009.03.020", "19429362"]}, {"Citation": "Kim E.C.; Lee H.S.; Kim S.K.; Choi M.S.; Lee S.; Han J.B.; An H.J.; Um J.Y.; Kim H.M.; Lee N.Y.; Bae H.; Min B.I.; The bark of Betula platyphylla var. japonica inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice. J Ethnopharmacol 2008,116(2),270-278", "ArticleIdList": ["10.1016/j.jep.2007.11.042", "18191513"]}, {"Citation": "Lee J.K.; Ha H.; Lee H.Y.; Park S.J.; Jeong S.; Choi Y.J.; Shin H.K.; Inhibitory effects of heartwood extracts of Broussonetia kazinoki Sieb on the development of atopic dermatitis in NC/Nga mice. Biosci Biotechnol Biochem 2010,74(9),1802-1806", "ArticleIdList": ["10.1271/bbb.100138", "20834170"]}, {"Citation": "Hong S.; Ku J.; Kim H.; Lee S.; Lim Y.; Seo H.; Shin Y.; Ko S.G.; Oral administration of Cervus nippon mantchuricus extract suppresses 2,4-dinitrochlorobenzene-induced atopic dermatitis in BALB/c mice and inflammatory effects in mast cells. Int J Mol Med 2018,42(5),2961-2971", "ArticleIdList": ["10.3892/ijmm.2018.3856", "30226556"]}, {"Citation": "Choi Y.Y.; Kim M.H.; Lee H.; Ahn K.S.; Um J.Y.; Lee S.; Kim J.; Yang W.M.; Cynanchum atratum inhibits the development of atopic dermatitis in 2,4-dinitrochlorobenzene-induced mice. Biomed Pharmacother 2017,90,321-327", "ArticleIdList": ["10.1016/j.biopha.2017.03.065", "28365521"]}, {"Citation": "Sung Y.Y.; Yoon T.; Jang J.Y.; Park S.J.; Jeong G.H.; Kim H.K.; Inhibitory effects of Cinnamomum cassia extract on atopic dermatitis-like skin lesions induced by mite antigen in NC/Nga mice. J Ethnopharmacol 2011,133(2),621-628", "ArticleIdList": ["10.1016/j.jep.2010.10.043", "21035532"]}, {"Citation": "Kim H.; Yang B.; Lyu J.H.; Kim S.; Park Y.C.; Kim K.; Dictamnus dasycarpus Turcz., root bark alleviates oxazolone-induced atopy-like dermatitis in mice. Pharmacogn Mag 2019,15(61),219", "ArticleIdList": ["10.4103/pm.pm_110_18"]}, {"Citation": "Sung Y.Y.; Yoon T.; Jang S.; Kim H.K.; Forsythia suspensa suppresses house dust mite extract-induced atopic dermatitis in NC/Nga mice. PLoS One 2016,11(12),e0167687", "ArticleIdList": ["10.1371/journal.pone.0167687", "27936051"]}, {"Citation": "Sung Y.Y.; Lee A.Y.; Kim H.K.; The Gardenia jasminoides extract and its constituent, geniposide, elicit anti-allergic effects on atopic dermatitis by inhibiting histamine in vitro and in vivo. J Ethnopharmacol 2014,156,33-40", "ArticleIdList": ["10.1016/j.jep.2014.07.060", "25153023"]}, {"Citation": "Kim T.; Park K.; Jung H.S.; Kong W.S.; Jeon D.; Lee S.H.; Evaluation of anti-atopic dermatitis activity of Hypsizigus marmoreus extract. Phytother Res 2014,28(10),1539-1546", "ArticleIdList": ["10.1002/ptr.5164", "24839932"]}, {"Citation": "Lim H.S.; Ha H.; Lee H.; Lee J.K.; Lee M.Y.; Shin H.K.; Morus alba L. suppresses the development of atopic dermatitis induced by the house dust mite in NC/Nga mice. BMC Complement Altern Med 2014,14(1),139", "ArticleIdList": ["10.1186/1472-6882-14-139", "24755250"]}, {"Citation": "Lee S-H.; Nam D.Y.; Seo M.S.; Lee S.H.; Alleviation of atopic dermatitis-related symptoms by Perilla frutescens Britton. Int J Mol Med 2011,28(5),733-737", "ArticleIdList": ["10.3892/ijmm.2011.763", "21811759"]}, {"Citation": "Jin J.H.; Ngoc T.M.; Bae K.; Kim Y.S.; Kim H.P.; Inhibition of experimental atopic dermatitis by rhubarb (rhizomes of Rheum tanguticum) and 5-lipoxygenase inhibition of its major constituent, emodin. Phytother Res 2011,25(5),755-759", "ArticleIdList": ["10.1002/ptr.3480", "21442678"]}, {"Citation": "Kang Y.H.; Shin H.M.; Inhibitory effects of Schizandra chinensis extract on atopic dermatitis in NC/Nga mice. Immunopharmacol Immunotoxicol 2012,34(2),292-298", "ArticleIdList": ["10.3109/08923973.2011.602689", "21854164"]}, {"Citation": "Kim J.; Lee I.; Park S.; Choue R.; Effects of Scutellariae radix and Aloe vera gel extracts on immunoglobulin E and cytokine levels in atopic dermatitis NC/Nga mice. J Ethnopharmacol 2010,132(2),529-532", "ArticleIdList": ["10.1016/j.jep.2010.08.049", "20817082"]}, {"Citation": "Kang S.Y.; Jung H.W.; Nam J.H.; Kim W.K.; Kang J.S.; Kim Y.H.; Cho C.W.; Cho C.W.; Park Y.K.; Bae H.S.; Effects of the fruit extract of Tribulus terrestris on skin inflammation in mice with oxazolone-induced atopic dermatitis through regulation of calcium channels, orai-1 and TRPV3, and mast cell activation. Evid Based Complement Alternat Med 2017,2017,1-12", "ArticleIdList": ["10.1155/2017/8312946", "29348776"]}, {"Citation": "Saeedi M.; Morteza-Semnani K.; Ghoreishi M-R.; The treatment of atopic dermatitis with licorice gel. J Dermatolog Treat 2003,14(3),153-157", "ArticleIdList": ["10.1080/09546630310014369", "14522625"]}, {"Citation": "Sirikudta W.; Kulthanan K.; Varothai S.; Nuchkull P.; Moisturizers for patients with atopic dermatitis: An overview. J Allergy Ther 2013,4(4),1-6", "ArticleIdList": ["10.4172/2155-6121.1000143"]}, {"Citation": "Gupta V.; Sanyogita K.; Manigauha A.; Novel Formulation of Aloe Vera and Quercetin in the Management of Dermal Disease: Eczema. J Pharm Drug Res 2021,4(2),480-487", "ArticleIdList": ["10.13140/RG.2.2.21014.27207"]}, {"Citation": "Ramos Campos E.V.; Proen\u00e7a P.L.D.F.; Doretto-Silva L.; Andrade-Oliveira V.; Fraceto L.F.; de Araujo D.R.; Trends in nanoformulations for atopic dermatitis treatment. Expert Opin Drug Deliv 2020,17(11),1615-1630", "ArticleIdList": ["10.1080/17425247.2020.1813107", "32816566"]}, {"Citation": "Mezei M.; Gulasekharam V.; Liposomes - a selective drug delivery system for the topical route of administration I. Lotion dosage form. Life Sci 1980,26(18),1473-1477", "ArticleIdList": ["10.1016/0024-3205(80)90268-4", "6893068"]}, {"Citation": "Krishnan V.; Mitragotri S.; Nanoparticles for topical drug delivery: Potential for skin cancer treatment. Adv Drug Deliv Rev 2020,153,87-108", "ArticleIdList": ["10.1016/j.addr.2020.05.011", "32497707"]}, {"Citation": "Raza K.; Shareef M.A.; Singal P.; Sharma G.; Negi P.; Katare O.P.; Lipid-based capsaicin-loaded nano-colloidal biocompatible topical carriers with enhanced analgesic potential and decreased dermal irritation. J Liposome Res 2014,24(4),290-296", "ArticleIdList": ["10.3109/08982104.2014.911314", "24766639"]}, {"Citation": "Abdel-Mottaleb M.M.A.; Moulari B.; Beduneau A.; Pellequer Y.; Lamprecht A.; Nanoparticles enhance therapeutic outcome in inflamed skin therapy. Eur J Pharm Biopharm 2012,82(1),151-157", "ArticleIdList": ["10.1016/j.ejpb.2012.06.006", "22728016"]}, {"Citation": "Badihi A.; Fru\u0161i\u0107-Zlotkin M.; Soroka Y.; Benhamron S.; Tzur T.; Nassar T.; Benita S.; Topical nano-encapsulated cyclosporine formulation for atopic dermatitis treatment. Nanomedicine 2020,24,102140", "ArticleIdList": ["10.1016/j.nano.2019.102140", "31830614"]}, {"Citation": "Baspinar Y.; Keck C.M.; Borchert H.H.; Development of a positively charged prednicarbate nanoemulsion. Int J Pharm 2010,383(1-2),201-208", "ArticleIdList": ["10.1016/j.ijpharm.2009.09.002", "19747968"]}, {"Citation": "Bernardi D.S.; Pereira T.A.; Maciel N.R.; Bortoloto J.; Viera G.S.; Oliveira G.C.; Rocha-Filho P.A.; Formation and stability of oil-in-water nanoemulsions containing rice bran oil: in vitro and in vivo assessments. J Nanobiotechnology 2011,9(1),44", "ArticleIdList": ["10.1186/1477-3155-9-44", "21952107"]}, {"Citation": "Espinoza L.C.; Silva-Abreu M.; Calpena A.C.; Rodr\u00edguez-Lagunas M.J.; F\u00e1brega M.J.; Gardu\u00f1o-Ram\u00edrez M.L.; Clares B.; Nanoemulsion strategy of pioglitazone for the treatment of skin inflammatory diseases. Nanomedicine 2019,19,115-125", "ArticleIdList": ["10.1016/j.nano.2019.03.017", "31004811"]}, {"Citation": "Hemrajani C.; Negi P.; Parashar A.; Gupta G.; Jha N.K.; Singh S.K.; Chellappan D.K.; Dua K.; Overcoming drug delivery barriers and challenges in topical therapy of atopic dermatitis: A nanotechnological perspective. Biomed Pharmacother 2022,147,112633", "ArticleIdList": ["10.1016/j.biopha.2022.112633", "35030434"]}, {"Citation": "Paiva-Santos A.C.; Silva A.L.; Guerra C.; Peixoto D.; Pereira-Silva M.; Zeinali M.; Mascarenhas-Melo F.; Castro R.; Veiga F.; Ethosomes as nanocarriers for the development of skin delivery formulations. Pharm Res 2021,38(6),947-970", "ArticleIdList": ["10.1007/s11095-021-03053-5", "34036520"]}, {"Citation": "Kang M.J.; Eum J.Y.; Jeong M.S.; Choi S.E.; Park S.H.; Cho H.I.; Cho C.S.; Seo S.J.; Lee M.W.; Choi Y.W.; Facilitated skin permeation of oregonin by elastic liposomal formulations and suppression of atopic dermatitis in NC/Nga mice. Biol Pharm Bull 2010,33(1),100-106", "ArticleIdList": ["10.1248/bpb.33.100", "20045944"]}, {"Citation": "Choi Y.; Kang ; Eum ; Jeong ; Park ; Moon ; Kang ; Choi S.E.; Lee M.W.; Lee D.I.; Bang H.; Lee C.S.; Joo S.S.; Li K.; Lee M.K.; Seo S.J.; Kim, ; Tat peptide-admixed elastic liposomal formulation of hirsutenone for the treatment of atopic dermatitis in Nc/Nga mice. Int J Nanomedicine 2011,6,2459-2467", "ArticleIdList": ["10.2147/IJN.S24350", "22072881"]}, {"Citation": "Priprem A.; Janpim K.; Nualkaew S.; Mahakunakorn P.; Topical niosome gel of Zingiber cassumunar Roxb. extract for anti-inflammatory activity enhanced skin permeation and stability of compound D. AAPS PharmSciTech 2016,17(3),631-639", "ArticleIdList": ["10.1208/s12249-015-0376-z", "26292930"]}, {"Citation": "Suryawanshi J.S.; Phytosome: An emerging trend in herbal drug treatment. J Med Genet Genomics 2011,3(6),109-114"}, {"Citation": "Vickers N.J.; Animal communication: When i\u2019m calling you, will you answer too? Curr Biol 2017,27(14),R713-R715", "ArticleIdList": ["10.1016/j.cub.2017.05.064", "28743020"]}, {"Citation": "Neelam K.; Vijay S.; Lalit S.; Various techniques for the modification of starch and the applications of its derivatives. Int Res J Pharm 2012,3(5),25-31"}, {"Citation": "Ju Ho P.; Jun Sung J.; Ki Cheon K.; Jin Tae H.; Anti-inflammatory effect of Centella asiatica phytosome in a mouse model of phthalic anhydride-induced atopic dermatitis. Phytomedicine 2018,43,110-119", "ArticleIdList": ["10.1016/j.phymed.2018.04.013", "29747743"]}, {"Citation": "Togni S.; Riva A.; Maramaldi G.; Cesarone M.R.; Belcaro G.; Oral curcumin (Meriva\u00ae) reduces symptoms and recurrence rates in subjects with atopic dermatitis. Esperienze Dermatol 2020,21(2-4),42-46", "ArticleIdList": ["10.23736/S1128-9155.19.00486-2"]}, {"Citation": "Kumari S.; Goyal A.; S\u00f6nmez G\u00fcrer E.; Alg\u0131n Yapar E.; Garg M.; Sood M.; Sindhu R.K.; Bioactive Loaded Novel Nano-Formulations for Targeted Drug Delivery and Their Therapeutic Potential. Pharmaceutics 2022,14(5),1091", "ArticleIdList": ["10.3390/pharmaceutics14051091", "35631677"]}, {"Citation": "Sahu S.; Saraf S.; Kaur C.D.; Saraf S.; Biocompatible nanoparticles for sustained topical delivery of anticancer phytoconstituent quercetin. Pak J Biol Sci 2013,16(13),601-609", "ArticleIdList": ["10.3923/pjbs.2013.601.609", "24505982"]}, {"Citation": "Wang Y.; Cao S.; Yu K.; Yang F.; Yu X.; Zhai Y.; Wu C.; Xu Y.; Integrating tacrolimus into eutectic oil-based microemulsion for atopic dermatitis: Simultaneously enhancing percutaneous delivery and treatment efficacy with relieving side effects. Int J Nanomedicine 2019,14,5849-5863", "ArticleIdList": ["10.2147/IJN.S212260", "31440050"]}, {"Citation": "Marto J.; Ruivo E.; Lucas S.D.; Gon\u00e7alves L.M.; Sim\u00f5es S.; Gouveia L.F.; Felix R.; Moreira R.; Ribeiro H.M.; Almeida A.J.; Starch nanocapsules containing a novel neutrophil elastase inhibitor with improved pharmaceutical performance. Eur J Pharm Biopharm 2018,127,1-11", "ArticleIdList": ["10.1016/j.ejpb.2018.01.011", "29409864"]}, {"Citation": "Mroginski Weber D.; Voss G.T.; de Oliveira R.L.; da Fonseca C.A.R.; Paltian J.; Rodrigues K.C.; Rodrigues Ianiski F.; Vaucher R.A.; Luchese C.; Antunes Wilhelm E.; Topic application of meloxicam-loaded polymeric nanocapsules as a technological alternative for treatment of the atopic dermatitis in mice. J Appl Biomed 2018,16(4),337-343", "ArticleIdList": ["10.1016/j.jab.2018.03.003"]}, {"Citation": "Parekh K.; Mehta T.A.; Dhas N.; Kumar P.; Popat A.; Emerging nanomedicines for the treatment of atopic dermatitis. AAPS PharmSciTech 2021,22(2),55", "ArticleIdList": ["10.1208/s12249-021-01920-3", "33486609"]}, {"Citation": "Kwon T.K.; Kim J.C.; In vitro skin permeation and anti-atopic efficacy of lipid nanocarriers containing water soluble extracts of Houttuynia cordata. Drug Dev Ind Pharm 2014,40(10),1350-1357", "ArticleIdList": ["10.3109/03639045.2013.819883", "23886304"]}, {"Citation": "Fang Ma; Traditional Chinese medicine for treating phytophotodermatitis. 2014"}, {"Citation": "Junior Dante Alario; Pereira Jose; Roberto Da Costa Topical pharmaceutical composition, method for producing the topical pharmaceutical composition, use of the topical pharmaceutical composition and method for the topical treatment of psoriasis, atopic dermatitis or chronic eczema. 2013"}, {"Citation": "Eun-kyung Ahn; Seong-soo Hong; Composition for Improving Atopy Dermatitis Using an Extract of Scirpus karuizawensis. 2022"}, {"Citation": "Kang Jae-Shin; Le Jaeho; Yoo Eunhwa; Cry Marsfal; Chang Kimsun; Composition for Improving Atopy Dermatitis Using an Extract of Careya arborea. 2020"}, {"Citation": "Jeon Minkyu; Shin-young Park; Kim Yunyeon; Composition for prevention and treatment of atopic dermatitis comprising bifidobacterium animal's subsp. lactis lm1017 derived from Korean infants. 2020"}, {"Citation": "Andr\u00e9 Philippe; Shantara Laurent; Lin Ink; Treatment of atopic dermatitis with extracts of indigo naturalis or indigo-producing plants. 2020"}, {"Citation": "Abdulrahman Muna; Abdulrahman Mohamed; Formulations for Cosmetic and Dermatological Applications. 2019"}, {"Citation": "Jing Ruan; Composition capable of relieving eczema skin condition, and preparation method therefor. 2021"}, {"Citation": "Yong-won Song; Composition for treating atopic dermatitis using natural materials. 2012"}, {"Citation": "Ga-young Noh; Jae-young Noh; Therapeutic effects cream for anti-atopic. 2013"}, {"Citation": "Oucrea Christian; Composition comprising dihydroquercetin for use in a method of treating an action associated with a skin inflammatory disorder. 2017"}, {"Citation": "Ahn Taekwon; Park Jungmi; Tae-soo Jang; Choi Heejeong; Pharmaceutical Compositions Comprising Aralia cordata var. continent- ails Composite oil Having Anti-atopy. 2020"}, {"Citation": "Seong-yul Park; Composition for treating atopic dermatitis comprising Patrinia scabiosaefolia and Dioscorea opposita extracts. 2020"}, {"Citation": "Ji-hwan Joo; Kim Donghee; Boo-yong Shim; A composite for improving atopic dermatitis treatment using apples. 2018"}, {"Citation": "Lee Hwanmyeong; Kim Doyoon; Hwang Daeil; Soo-min Park; Kim Miyeon; Lee Sehee; Composition for treating atopic dermatitis or reinforcing skin barrier containing chrysanthemum bore-ale makino essential oil or 1-iodohexadecan. 2019"}, {"Citation": "Jeong Hyeoksang; Son Youngjoo; Park Jaeho; Eun-young Kim; Composition comprising Fritillariae Thunbergii Bulbs extract for preventing or treating atopic dermatitis. 2021"}, {"Citation": "Jeong Hyeoksang; Son Youngjoo; Jwa-jin Kim; Park Jaeho; Eun-young Kim; Ga-yul Min; A composition for preventing or terating atopic dermatitis comprising lycopi herba extract as an active ingredient. 2020"}, {"Citation": "Dae-hyun Ham; Hye-jeong Lee; Bong-joon Seo; Composition comprising Polygala tenuifolia extract for preventing or treating atopic dermatitis. 2015"}, {"Citation": "Jang Seonil; Composition for preventing, improving or treating atopic dermatitis comprising extract mixture of Diospyros lotus leaf and grape fruit stem as effective component. 2019"}, {"Citation": "Yang Jaekyung; Kim Rumi; Hasiyoung Jongcheol Kim; Kim Taeheung; Ji-young Jeong; Seung-cheol Park; Composition for improving atopic dermatitis comprising extract of steamed green tea. 2013"}, {"Citation": "Cai Ruikang; Yuan Hailong; Yan Wu; Shen Chengying; Rong Xu; Si Zhang; Traditional Chinese medicine composition and granules for treating atopic dermatitis and preparation method. 2020"}, {"Citation": "Chen Dacan; Chinese medicinal composition for treating atopic dermatitis and preparation method thereof. 2015"}, {"Citation": "Fever Margin; Tae-ho Jeong; Composition for preventing or treating atopic dermatitis including galenical extract or lactobacillus fermentation thereof. 2012"}, {"Citation": "Hyun-sook Kim; Atopic dermatitis remedy and method for producing the same. 2019"}, {"Citation": "Hwang, ; Incheol Manufacturing method of composition comprising natural extracts for treating atopic dermatitis. 2016"}, {"Citation": "Ahuja A.; Gupta J.; Gupta R.; Miracles of herbal phytomedicines in treatment of skin disorders: Natural healthcare perspective. Infect Disord Drug Targets 2021,21(3),328-338", "ArticleIdList": ["10.2174/1871526520666200622142710", "32568024"]}, {"Citation": "Garg A.; Chaturvedi S.; A Comprehensive Review on Chrysin: Emphasis on Molecular Targets, Pharmacological Actions and Bio-pharmaceutical Aspects. Curr Drug Targets 2022,23(4),420-436", "ArticleIdList": ["10.2174/1389450122666210824141044", "34431464"]}, {"Citation": "Cl\u00e1udia Paiva-Santos A.; Gama M.; Peixoto D.; Sousa-Oliveira I.; Ferreira-Faria I.; Zeinali M.; Abbaspour-Ravasjani S.; Mascarenhas-Melo F.; Hamishehkar H.; Veiga F.; Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis. Int J Pharm 2022,618,121656", "ArticleIdList": ["10.1016/j.ijpharm.2022.121656", "35278601"]}, {"Citation": "Chaturvedi S.; Garg A.; Verma A.; Nano lipid based carriers for lymphatic voyage of anti-cancer drugs: An insight into the in-vitro, ex-vivo, in-situ and in-vivo study models. J Drug Deliv Sci Technol 2020,59,101899", "ArticleIdList": ["10.1016/j.jddst.2020.101899"]}, {"Citation": "Chaturvedi S.; Garg A.; An insight of techniques for the assessment of permeation flux across the skin for optimization of topical and transdermal drug delivery systems. J Drug Deliv Sci Technol 2021,62,102355", "ArticleIdList": ["10.1016/j.jddst.2021.102355"]}, {"Citation": "Grabarek B.O.; D\u0105bala M.; Kasela T.; Gralewski M.; G\u0142adysz D.; Changes in the expression pattern of DUSP1-7 and miRNA regulating their expression in the keratinocytes treated with LPS and adalimumab. Curr Pharm Biotechnol 2022,23(6),873-881", "ArticleIdList": ["10.2174/1389201022666210802102508", "34342258"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "1", "Day": "14"}, {"Year": "2023", "Month": "6", "Day": "23"}, {"Year": "2023", "Month": "7", "Day": "6"}, {"Year": "2024", "Month": "6", "Day": "6", "Hour": "12", "Minute": "45"}, {"Year": "2023", "Month": "10", "Day": "27", "Hour": "12", "Minute": "42"}, {"Year": "2023", "Month": "10", "Day": "27", "Hour": "7", "Minute": "34"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37888809", "10.2174/0113892010245092230922180341", "CPB-EPUB-134862"]}}], "PubmedBookArticle": []}